Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hypersensitivity Reaction

  Free Subscription


Articles published in Respir Med

Retrieve available abstracts of 93 articles:
HTML format
Text format



Single Articles


    December 2017
  1. PERISSON C, Destruys L, Grenet D, Bassinet L, et al
    Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis.
    Respir Med. 2017;133:12-15.
    PubMed     Text format     Abstract available


    October 2017
  2. ZIERAU L, Walsted ES, Thomsen SF, Backer V, et al
    Response to omalizumab in patients with severe allergic asthma: A real-life study.
    Respir Med. 2017;131:109-113.
    PubMed     Text format     Abstract available


    August 2017
  3. WOGE MJ, Ryu JH, Moua T
    Diagnostic implications of positive avian serology in suspected hypersensitivity pneumonitis.
    Respir Med. 2017;129:173-178.
    PubMed     Text format     Abstract available


    May 2017
  4. SCHOR D, Rizzo JA, Medeiros D, Dela Bianca AC, et al
    Home-made spacer as an auxiliary device in administration of beclomethasone via pressurized metered dose inhaler for asthma control. A randomized controlled pragmatic trial.
    Respir Med. 2017;126:52-58.
    PubMed     Text format     Abstract available


  5. NELSEN LM, Kimel M, Murray LT, Ortega H, et al
    Qualitative evaluation of the St George's Respiratory Questionnaire in patients with severe asthma.
    Respir Med. 2017;126:32-38.
    PubMed     Text format     Abstract available


  6. FERRER GALVAN M, Javier Alvarez Gutierrez F, Romero Falcon A, Romero Romero B, et al
    Is the bronchodilator test an useful tool to measure asthma control?
    Respir Med. 2017;126:26-31.
    PubMed     Text format     Abstract available


    March 2017
  7. MANSUR AH, Srivastava S, Mitchell V, Sullivan J, et al
    Longterm clinical outcomes of omalizumab therapy in severe allergic asthma: Study of efficacy and safety.
    Respir Med. 2017;124:36-43.
    PubMed     Text format     Abstract available


  8. ROGLIANI P, Calzetta L, Coppola A, Cavalli F, et al
    Optimizing drug delivery in COPD: The role of inhaler devices.
    Respir Med. 2017;124:6-14.
    PubMed     Text format     Abstract available


  9. TIWARI A, Rahman K, Abejie B, Jain VV, et al
    Longer duration of asthma is significantly associated with increased RV/TLC ratio.
    Respir Med. 2017;124:44-48.
    PubMed     Text format     Abstract available


  10. VON BULOW A, Backer V, Bodtger U, Soes-Petersen NU, et al
    The level of diagnostic assessment in severe asthma: A nationwide real-life study.
    Respir Med. 2017;124:21-29.
    PubMed     Text format     Abstract available


    February 2017
  11. LEE JU, Chang HS, Lee HJ, Bae DJ, et al
    Association of interleukin-25 levels with development of aspirin induced respiratory diseases.
    Respir Med. 2017;123:71-78.
    PubMed     Text format     Abstract available


  12. VEIDAL S, Jeppegaard M, Sverrild A, Backer V, et al
    The impact of dysfunctional breathing on the assessment of asthma control.
    Respir Med. 2017;123:42-47.
    PubMed     Text format     Abstract available


  13. BJERREGAARD A, Laing IA, Poulsen N, Backer V, et al
    Characteristics associated with clinical severity and inflammatory phenotype of naturally occurring virus-induced exacerbations of asthma in adults.
    Respir Med. 2017;123:34-41.
    PubMed     Text format     Abstract available


  14. COCKLE SM, Stynes G, Gunsoy NB, Parks D, et al
    Comparative effectiveness of mepolizumab and omalizumab in severe asthma: An indirect treatment comparison.
    Respir Med. 2017;123:140-148.
    PubMed     Text format     Abstract available


  15. VARSANO S, Segev D, Shitrit D
    Severe and non-severe asthma in the community: A large electronic database analysis.
    Respir Med. 2017;123:131-139.
    PubMed     Text format     Abstract available


  16. TAKAKU Y, Kurashima K, Ohta C, Ishiguro T, et al
    How many instructions are required to correct inhalation errors in patients with asthma and chronic obstructive pulmonary disease?
    Respir Med. 2017;123:110-115.
    PubMed     Text format     Abstract available


    January 2017
  17. LI JX, Fan LC, Li MH, Cao WJ, et al
    Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature.
    Respir Med. 2017;122:33-42.
    PubMed     Text format     Abstract available


  18. ADEYEYE OO, Adewumi TA, Adewuya AO
    Effect of psychological and other factors on quality of life amongst asthma outpatients in Lagos, Nigeria.
    Respir Med. 2017;122:67-70.
    PubMed     Text format     Abstract available


  19. HALLIT S, Raherison C, Waked M, Salameh P, et al
    Validation of asthma control questionnaire and risk factors affecting uncontrolled asthma among the Lebanese children's population.
    Respir Med. 2017;122:51-57.
    PubMed     Text format     Abstract available


    December 2016
  20. DENG Q, Lu C, Yu Y, Li Y, et al
    Early life exposure to traffic-related air pollution and allergic rhinitis in preschool children.
    Respir Med. 2016;121:67-73.
    PubMed     Text format     Abstract available


  21. CHECKLEY W, Deza MP, Klawitter J, Romero KM, et al
    Identifying biomarkers for asthma diagnosis using targeted metabolomics approaches.
    Respir Med. 2016;121:59-66.
    PubMed     Text format     Abstract available


  22. CHEN JH, Qin L, Shi YY, Feng JT, et al
    IL-17 protein levels in both induced sputum and plasma are increased in stable but not acute asthma individuals with obesity.
    Respir Med. 2016;121:48-58.
    PubMed     Text format     Abstract available


  23. COMARU T, Pitrez PM, Friedrich FO, Silveira VD, et al
    Free asthma medications reduces hospital admissions in Brazil (Free asthma drugs reduces hospitalizations in Brazil).
    Respir Med. 2016;121:21-25.
    PubMed     Text format     Abstract available


    November 2016
  24. ADACHI M, Goldfrad C, Jacques L, Nishimura Y, et al
    Efficacy and safety comparison: Fluticasone furoate and fluticasone propionate, after step down from fluticasone furoate/vilanterol in Japanese patients with well-controlled asthma, a randomized trial.
    Respir Med. 2016;120:78-86.
    PubMed     Text format     Abstract available


  25. JANSSON SA, Axelsson M, Hedman L, Leander M, et al
    Subjects with well-controlled asthma have similar health-related quality of life as subjects without asthma.
    Respir Med. 2016;120:64-69.
    PubMed     Text format     Abstract available


  26. DEL GIACCO SR, Cappai A, Gambula L, Cabras S, et al
    The asthma-anxiety connection.
    Respir Med. 2016;120:44-53.
    PubMed     Text format     Abstract available


  27. LAHELMA S, Vahteristo M, Metev H, Taseva M, et al
    Equivalent bronchodilation with budesonide/formoterol combination via Easyhaler and Turbuhaler in patients with asthma.
    Respir Med. 2016;120:31-35.
    PubMed     Text format     Abstract available


  28. ALI Z, Nilas L, Ulrik CS
    Low risk of adverse obstetrical and perinatal outcome in pregnancies complicated by asthma: A case control study.
    Respir Med. 2016;120:124-130.
    PubMed     Text format     Abstract available


  29. APIKOGLU-RABUS S, Yesilyaprak G, Izzettin FV
    Drug-related problems and pharmacist interventions in a cohort of patients with asthma and chronic obstructive pulmonary disease.
    Respir Med. 2016;120:109-115.
    PubMed     Text format     Abstract available


  30. LARSEN K, Faulkner GE, Boak A, Hamilton HA, et al
    Looking beyond cigarettes: Are Ontario adolescents with asthma less likely to smoke e-cigarettes, marijuana, waterpipes or tobacco cigarettes?
    Respir Med. 2016;120:10-15.
    PubMed     Text format     Abstract available


    October 2016
  31. ARFE A, Blasi F, Merlino L, Corrao G, et al
    Respiratory drugs and macrolides prevent asthma exacerbations: A real-world investigation.
    Respir Med. 2016;119:7-12.
    PubMed     Text format     Abstract available


  32. ENGELKES M, Janssens HM, de Ridder MA, Sturkenboom MC, et al
    Real life data on incidence and risk factors of severe asthma exacerbations in children in primary care.
    Respir Med. 2016;119:48-54.
    PubMed     Text format     Abstract available


  33. ZIERAU L, Gade EJ, Lindenberg S, Backer V, et al
    Coexistence of asthma and polycystic ovary syndrome: A concise review.
    Respir Med. 2016;119:155-159.
    PubMed     Text format     Abstract available


  34. SPOSATO B, Scalese M, Latorre M, Scichilone N, et al
    Effects of omalizumab in severe asthmatics across ages: A real life Italian experience.
    Respir Med. 2016;119:141-149.
    PubMed     Text format     Abstract available


  35. PETHERICK ES, Pearce N, Sunyer J, Wright J, et al
    Ethnic and socio-economic differences in the prevalence of wheeze, severe wheeze, asthma, eczema and medication usage at 4 years of age: Findings from the Born in Bradford birth cohort.
    Respir Med. 2016;119:122-129.
    PubMed     Text format     Abstract available


  36. BRAITHWAITE I, Williams M, Power S, Pilcher J, et al
    Randomised, double-blind, placebo-controlled, cross-over single dose study of the bronchodilator duration of action of combination fluticasone furoate/vilanterol inhaler in adult asthma.
    Respir Med. 2016;119:115-121.
    PubMed     Text format     Abstract available


  37. EFTEKHARI P, Forder PM, Majeed T, Byles JE, et al
    Impact of asthma on mortality in older women: An Australian cohort study of 10,413 women.
    Respir Med. 2016;119:102-108.
    PubMed     Text format     Abstract available


  38. MORI K, Fujisawa T, Inui N, Hashimoto D, et al
    Step-down treatment from medium-dosage of budesonide/formoterol in controlled asthma.
    Respir Med. 2016;119:1-6.
    PubMed     Text format     Abstract available


    September 2016
  39. GIANNIOU N, Katsaounou P, Dima E, Giannakopoulou CE, et al
    Prolonged occupational exposure leads to allergic airway sensitization and chronic airway and systemic inflammation in professional firefighters.
    Respir Med. 2016;118:7-14.
    PubMed     Text format     Abstract available


  40. WESTERHOF GA, de Groot JC, Amelink M, de Nijs SB, et al
    Predictors of frequent exacerbations in (ex)smoking and never smoking adults with severe asthma.
    Respir Med. 2016;118:122-7.
    PubMed     Text format     Abstract available


  41. GRZELA K, Litwiniuk M, Krejner A, Zagorska W, et al
    Increased angiogenic factors in exhaled breath condensate of children with severe asthma - New markers of disease progression?
    Respir Med. 2016;118:119-21.
    PubMed     Text format     Abstract available


  42. DAHL R, Engel M, Dusser D, Halpin D, et al
    Safety and tolerability of once-daily tiotropium Respimat((R)) as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysis.
    Respir Med. 2016;118:102-11.
    PubMed     Text format     Abstract available


  43. BLAIS CM, Davis BE, Cockcroft DW
    Duration of bronchoprotection of the long-acting muscarinic antagonists tiotropium & glycopyrronium against methacholine-induced bronchoconstriction in mild asthmatics.
    Respir Med. 2016;118:96-101.
    PubMed     Text format     Abstract available


  44. KONDLA A, Glaab T, Pedersini R, Lommatzsch M, et al
    Asthma control in patients treated with inhaled corticosteroids and long-acting beta agonists: A population-based analysis in Germany.
    Respir Med. 2016;118:58-64.
    PubMed     Text format     Abstract available


  45. CHAUDHURI R, McSharry C, Heaney LG, Niven R, et al
    Effects of older age and age of asthma onset on clinical and inflammatory variables in severe refractory asthma.
    Respir Med. 2016;118:46-52.
    PubMed     Text format     Abstract available


  46. SELGE C, Thomas S, Nowak D, Radon K, et al
    Asthma prevalence in German Olympic athletes: A comparison of winter and summer sport disciplines.
    Respir Med. 2016;118:15-21.
    PubMed     Text format     Abstract available


  47. SUAREZ-MEDINA R, Venero-Fernandez SJ, Britton J, Fogarty AW, et al
    Population-based weight loss and gain do not explain trends in asthma mortality in Cuba: A prospective study from 1964 to 2014.
    Respir Med. 2016;118:4-6.
    PubMed     Text format     Abstract available


  48. TAN JH, Hsu AA
    Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link.
    Respir Med. 2016;118:1-3.
    PubMed     Text format     Abstract available


    August 2016
  49. MATULONGA B, Rava M, Siroux V, Bernard A, et al
    Women using bleach for home cleaning are at increased risk of non-allergic asthma.
    Respir Med. 2016;117:264-71.
    PubMed     Text format     Abstract available


  50. KERSTJENS HA, Moroni-Zentgraf P, Tashkin DP, Dahl R, et al
    Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status.
    Respir Med. 2016;117:198-206.
    PubMed     Text format     Abstract available


  51. BECERRA MB, Becerra BJ, Teodorescu M
    Healthcare burden of obstructive sleep apnea and obesity among asthma hospitalizations: Results from the U.S.-based Nationwide Inpatient Sample.
    Respir Med. 2016;117:230-6.
    PubMed     Text format     Abstract available


  52. TUOMISTO LE, Ilmarinen P, Niemela O, Haanpaa J, et al
    A 12-year prognosis of adult-onset asthma: Seinajoki Adult Asthma Study.
    Respir Med. 2016;117:223-9.
    PubMed     Text format     Abstract available


  53. RADHAKRISHNA N, Tay TR, Hore-Lacy F, Hoy R, et al
    Profile of difficult to treat asthma patients referred for systematic assessment.
    Respir Med. 2016;117:166-73.
    PubMed     Text format     Abstract available


  54. NAQVI M, Khachi H
    The barriers to accessing primary care resulting in hospital presentation for exacerbation of asthma or chronic obstructive pulmonary disease in a large teaching hospital in London.
    Respir Med. 2016;117:162-5.
    PubMed     Text format     Abstract available


  55. LICCARDI G, Salzillo A, Calzetta L, Cazzola M, et al
    Can bronchial asthma with an highly prevalent airway (and systemic) vagal tone be considered an independent asthma phenotype? Possible role of anticholinergics.
    Respir Med. 2016;117:150-3.
    PubMed     Text format     Abstract available


  56. GORSKA K, Korczynski P, Mierzejewski M, Kosciuch J, et al
    Comparison of endobronchial ultrasound and high resolution computed tomography as tools for airway wall imaging in asthma and chronic obstructive pulmonary disease.
    Respir Med. 2016;117:131-8.
    PubMed     Text format     Abstract available


  57. VERMEULEN F, Garcia G, Ninane V, Laveneziana P, et al
    Activity limitation and exertional dyspnea in adult asthmatic patients: What do we know?
    Respir Med. 2016;117:122-30.
    PubMed     Text format     Abstract available


  58. KOSKELA HO, Purokivi MK, Kokkarinen J
    Stepping down from combination asthma therapy: The predictors of outcome.
    Respir Med. 2016;117:109-15.
    PubMed     Text format     Abstract available


  59. KJELLBERG S, Houltz BK, Zetterstrom O, Robinson PD, et al
    Clinical characteristics of adult asthma associated with small airway dysfunction.
    Respir Med. 2016;117:92-102.
    PubMed     Text format     Abstract available


    July 2016
  60. SUAREZ-CUARTIN G, Chalmers JD, Sibila O
    Diagnostic challenges of bronchiectasis.
    Respir Med. 2016;116:70-7.
    PubMed     Text format     Abstract available


  61. MIRABELLI MC, Hsu J, Gower WA
    Comorbidities of asthma in U.S. children.
    Respir Med. 2016;116:34-40.
    PubMed     Text format     Abstract available


  62. USMANI OS, Singh D, Spinola M, Bizzi A, et al
    The prevalence of small airways disease in adult asthma: A systematic literature review.
    Respir Med. 2016;116:19-27.
    PubMed     Text format     Abstract available


    June 2016
  63. BUHL R, Korn S, Menzies-Gow A, Aubier M, et al
    Assessing biomarkers in a real-world severe asthma study (ARIETTA).
    Respir Med. 2016;115:7-12.
    PubMed     Text format     Abstract available


  64. OHRMALM L, Malinovschi A, Wong M, Levinson P, et al
    Presence of rhinovirus in the respiratory tract of adolescents and young adults with asthma without symptoms of infection.
    Respir Med. 2016;115:1-6.
    PubMed     Text format     Abstract available


    April 2016
  65. HYRKAS H, Ikaheimo TM, Jaakkola JJ, Jaakkola MS, et al
    Asthma control and cold weather-related respiratory symptoms.
    Respir Med. 2016;113:1-7.
    PubMed     Text format     Abstract available


    March 2016
  66. ONATIBIA-ASTIBIA A, Martinez-Pinilla E, Franco R
    The potential of methylxanthine-based therapies in pediatric respiratory tract diseases.
    Respir Med. 2016;112:1-9.
    PubMed     Text format     Abstract available


  67. DISANTOSTEFANO RL, Hinds D, Le HV, Barnes NC, et al
    Relationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohort.
    Respir Med. 2016;112:88-96.
    PubMed     Text format     Abstract available


  68. NIN CS, de Souza VV, do Amaral RH, Schuhmacher Neto R, et al
    Thoracic lymphadenopathy in benign diseases: A state of the art review.
    Respir Med. 2016;112:10-7.
    PubMed     Text format     Abstract available


  69. STELMACH I, Cichalewski L, Majak P, Smejda K, et al
    School environmental factors are predictive for exercise-induced symptoms in children.
    Respir Med. 2016;112:25-30.
    PubMed     Text format     Abstract available


    February 2016
  70. VAN DER EYCKEN S, Schelpe A, Marijsse G, Dilissen E, et al
    Feasibility to apply eucapnic voluntary hyperventilation in young elite athletes.
    Respir Med. 2016;111:91-3.
    PubMed     Text format     Abstract available


    January 2016
  71. FLAMENT T, Marchand-Adam S, Gatault P, Dupin C, et al
    What are the characteristics of asthma patients with elevated serum IgG4 levels?
    Respir Med. 2016 Jan 22. pii: S0954-6111(16)30011.
    PubMed     Text format     Abstract available


  72. HEFFLER E, Crimi C, Campisi R, Sichili S, et al
    Bronchodilator response as a marker of poor asthma control.
    Respir Med. 2016 Jan 22. pii: S0954-6111(16)30009.
    PubMed     Text format     Abstract available


  73. PANEK M, Mokros L, Pietras T, Kuna P, et al
    The epidemiology of asthma and its comorbidities in Poland - Health problems of patients with severe asthma as evidenced in the Province of Lodz.
    Respir Med. 2016 Jan 20. pii: S0954-6111(16)30005.
    PubMed     Text format     Abstract available


  74. KEMPSFORD RD, Bal J, Baines A, Renaux J, et al
    The efficacy of fluticasone furoate administered in the morning or evening is comparable in patients with persistent asthma.
    Respir Med. 2016 Jan 12. pii: S0954-6111(15)30102.
    PubMed     Text format     Abstract available


  75. PHAM TH, Damera G, Newbold P, Ranade K, et al
    Reductions in eosinophil biomarkers by benralizumab in patients with asthma.
    Respir Med. 2016 Jan 8. pii: S0954-6111(16)30003.
    PubMed     Text format     Abstract available


  76. MAIO S, Baldacci S, Carrozzi L, Pistelli F, et al
    Respiratory symptoms/diseases prevalence is still increasing: a 25-yr population study.
    Respir Med. 2016;110:58-65.
    PubMed     Text format     Abstract available


    December 2015
  77. BACKER V, Baines KJ, Powell H, Porsbjerg C, et al
    Increased asthma and adipose tissue inflammatory gene expression with obesity and Inuit migration to a western country.
    Respir Med. 2015 Dec 19. pii: S0954-6111(15)30094.
    PubMed     Text format     Abstract available


  78. KALLIOLA S, Malmberg LP, Pelkonen AS, Makela MJ, et al
    Aberrant small airways function relates to asthma severity in young children.
    Respir Med. 2015 Dec 19. pii: S0954-6111(15)30097.
    PubMed     Text format     Abstract available


  79. POLVERINO E, Torres A, Terraneo S
    Community acquired pneumonia in asthma: Not a threatening combination.
    Respir Med. 2015 Dec 8. pii: S0954-6111(15)00335.
    PubMed     Text format    


    November 2015
  80. ERBABACAN E, M Koksal G, Esquinas AM
    Severity of community acquired pneumonia in asthma patients. How and what are linked?
    Respir Med. 2015 Nov 27. pii: S0954-6111(15)00334.
    PubMed     Text format    


  81. LIU H, Xu C, Jiang ZY, Gu A, et al
    Association of polycyclic aromatic hydrocarbons and asthma among children 6-19 years: NHANES 2001-2008 and NHANES 2011-2012.
    Respir Med. 2015 Nov 10. pii: S0954-6111(15)30084.
    PubMed     Text format     Abstract available


  82. AALBERS R, Vogelmeier C, Kuna P
    Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention.
    Respir Med. 2015 Nov 6. pii: S0954-6111(15)30083.
    PubMed     Text format     Abstract available


  83. DEKHUIJZEN PN
    Guidance on handheld inhalers in asthma and COPD guidelines: An update.
    Respir Med. 2015 Nov 3. pii: S0954-6111(15)30081.
    PubMed     Text format    


    October 2015
  84. DJUKANOVIC R, Hanania N, Busse W, Price D, et al
    IgE-mediated asthma: New revelations and future insights.
    Respir Med. 2015 Oct 30. pii: S0954-6111(15)30077.
    PubMed     Text format     Abstract available


  85. LIU T, Wu J, Zhao J, Wang J, et al
    Type 2 innate lymphoid cells: A novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma.
    Respir Med. 2015 Oct 9. pii: S0954-6111(15)30063.
    PubMed     Text format     Abstract available


  86. WURST KE, Kelly-Reif K, Bushnell GA, Pascoe S, et al
    Understanding asthma-chronic obstructive pulmonary disease overlap syndrome.
    Respir Med. 2015 Oct 9. pii: S0954-6111(15)30068.
    PubMed     Text format     Abstract available


    September 2015
  87. CORTES-TELLES A, Torre-Bouscoulet L, Silva-Ceron M, Mejia-Alfaro R, et al
    Combined effects of mild-to-moderate obesity and asthma on physiological and sensory responses to exercise.
    Respir Med. 2015 Sep 25. pii: S0954-6111(15)30057.
    PubMed     Text format     Abstract available


  88. KONSTANTELLOU E, Papaioannou AI, Loukides S, Patentalakis G, et al
    Persistent airflow obstruction in patients with asthma: Characteristics of a distinct clinical phenotype.
    Respir Med. 2015 Sep 21. pii: S0954-6111(15)30056.
    PubMed     Text format     Abstract available


  89. LOWES D, Chishimba L, Greaves M, Denning DW, et al
    Development of chronic pulmonary aspergillosis in adult asthmatics with ABPA.
    Respir Med. 2015 Sep 12. pii: S0954-6111(15)30055.
    PubMed     Text format     Abstract available


    July 2015
  90. WESTERGAARD CG, Porsbjerg C, Backer V
    The effect of Varenicline on smoking cessation in a group of young asthma patients.
    Respir Med. 2015 Jul 30. pii: S0954-6111(15)30032.
    PubMed     Text format     Abstract available


  91. KLOK T, Kaptein AA, Duiverman EJ, Brand PL, et al
    Long-term adherence to inhaled corticosteroids in children with asthma: Observational study.
    Respir Med. 2015 Jul 26. pii: S0954-6111(15)30031.
    PubMed     Text format     Abstract available


  92. HASEGAWA K, Stoll SJ, Ahn J, Bittner JC, et al
    Prevalence of eosinophilia in hospitalized patients with asthma exacerbation.
    Respir Med. 2015 Jul 17. pii: S0954-6111(15)30026.
    PubMed     Text format     Abstract available


  93. DEMIRCA BP, Cagan H, Kiykim A, Arig U, et al
    Nebulized fluticasone propionate, a viable alternative to systemic route in the management of childhood moderate asthma attack: A double-blind, double-dummy study.
    Respir Med. 2015 Jul 14. pii: S0954-6111(15)30022.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: